MicroRNA-421 inhibits caspase-10 expression and promotes breast cancer progression

31Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Breast cancer is one of the most prevalent and fatal diseases around the world. The mechanism of tumorigenesis in breast cancer remains to be clarified. miR-421 plays an oncogenic role in many cancers. Although, the clinical significance of miR-421 in patients with breast cancer is still to be investigated. Caspase-10 is one of the initiator of apoptosis. But the relationship between miR-421 and caspase-10 has not been investigated. In the present study, we found that miR-421 was expressed much higher in breast cancer tissues compared to those in adjacent non-tumor tissues. Furthermore, miR-421 promotes cell proliferation and colony formation in vitro. miR-421 inhibits cell apoptosis probably through restraining caspase-10 expression. Thus, miR-421 might be a potential diagnostic maker and therapeutic target for breast cancer.

Cite

CITATION STYLE

APA

Hu, T. B., Chen, H. S., Cao, M. Q., Guo, F. D., Cheng, X. Y., Han, Z. B., & Li, M. Q. (2018). MicroRNA-421 inhibits caspase-10 expression and promotes breast cancer progression. Neoplasma, 65(1), 49–54. https://doi.org/10.4149/neo_2018_170306N159

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free